ZIELGERICHTETE THERAPEUTIKA

Patent europeic · EP3129064 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3129064
Numer da la dumonda
EP15758717
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
03-03-2015
Publitgà
15-02-2017
Concedì
01-01-2020
Stritgà
31-03-2020
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 47/50 (2017.01)
Prioritad
US 201461947108 P 03.03.2014
Dumonda PCT
PCT/US2015/018442 03.03.2015
Publicaziun PCT
WO2015/134464 11.09.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-10-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.10.2020

  2. 01-01-2020

    Concedì

    Published in Swissreg on 01.01.2020

Partidas

Possessur

Madrigal Pharmaceuticals, Inc.

Four Tower Bridge 200 Barr Harbor Drive, Suite 400, West Conshohocken, Pennsylvania 19428, US

Inventur

CHIMMANAMADA, Dinesh, U.

Arlington, MA 02474, US

YING, Weiwen

Lexington MA 02421, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.